Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001430 (
adenoma
)
21,222
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects on the pancreas of chronic (95 wk) dietary exposure to protease inhibitors from soy and potato were compared in rats and mice. Soy and potato
trypsin inhibitor
(TI) concentrates were prepared from defatted raw soy flour and potato juice, respectively, by selective precipitation and ultrafiltration. Animals were fed a diet in which casein supplied approximately 20% protein. Each concentrate (less than 1% of the diet) was added to provide 100 and 200 mg of
trypsin inhibitor
activity per 100 g of diet. In short-term (28 d) experiments in rats, both sources of TI decreased the apparent nutritional quality of casein and produced pancreatic hypertrophy consistent with a hormonally mediated feedback mechanism for pancreatic adaptation to diet that is interactive with the nutritional status of the animal. After long-term feeding (95 wk), soy and potato TI produced dose-related pancreatic pathology in rats consisting of nodular hyperplasia and acinar
adenoma
, which was typical of that associated with raw soy flour. Although mice responded similarly to rats to soy TI in short-term (28-d) feeding experiments, they were resistant to the formation of these lesions following long-term feeding. This considerable species variation in propensity to develop preneoplastic and neoplastic lesions of the pancreas is not predicted by the short-term hypertrophic and hyperplastic response of the pancreas to TI.
...
PMID:Pancreatic response in rats and mice to trypsin inhibitors from soy and potato after short- and long-term dietary exposure. 260 Jun 65
Feeding soy-based protein containing
trypsin inhibitor
causes pancreatic hypertrophy in the rat, and long-term feeding (up to 2 years) has revealed a high incidence of
adenoma
following hypertrophy. It was therefore of interest to determine whether the ingestion of soy-based protein has any adverse effects on the primate pancreas. A resource of 27 Cebus albifrons monkeys, previously used to evaluate the protein quality of several soy and milk proteins, has been maintained on semi-synthetic diets for 3 to 4 years; the protein sources for the diets were casein, lactalbumin, soy isolate and soy concentrate. In general the monkeys were in good physical health and their weights were appropriate for age and sex. Serum biochemical and hematological profiles were normal and there were no major differences between the groups. A pancreatic biopsy from both the head and tail region of the pancreas was taken from each monkey. Visual observation of the pancreas revealed no overt pathology; two independent histological examinations indicated no diet-related differences between groups, and biochemical analyses of trypsin, chymotrypsin, protein, DNA and RNA revealed no differences. It is concluded that feeding low level
trypsin inhibitor
-containing diets for up to 4 years caused no adverse effects in the pancreas of the Cebus nonhuman primate.
...
PMID:Effect of long-term feeding of soy-based diets on the pancreas of Cebus monkeys. 379 78
The effects on the pancreas of chronic dietary exposure to defatted soy flour and soy protein isolate have been studied in two two-year feeding trials in rats. Emphasis was placed on detecting changes that might accompany low levels of dietary
trypsin inhibitor
(TI) as might be found in edible grade soy products and on studying the influence of protein nutrition. The major pathological findings in the pancreas were nodular hyperplasia (NH), consisting of foci of hyperplastic acinar cells often grossly visible by six months, and the benign neoplastic lesion, acinar
adenoma
(AA), which developed more slowly. In the first feeding trial, the objectives were to obtain the dose-response relationship of pancreatic pathology to dietary TI provided by raw and heated soy flour and to study the nutritional interaction of protein level which was varied from 10% to 30% using casein supplementation. Also, the responses to raw and heated soy protein isolate were compared to determine whether the removal of more than 50% of the constituents found in soy flour would alter the development of pancreatic lesions. In the second trial, the effect of unusually low levels of TI in raw and heat-treated soy protein isolate, prepared through a salt extraction process and fed at 10% and 30% protein in the diet, was investigated. The incidence of both NH and AA was positively related to the TI content of the diet. The probit transformation of the percent incidence of AA was linearly related to the log of TI/g protein in the diet. A single curve best described the response to 20% and 30% protein, with a slope that was distinctly greater than that for 10% protein. The intersection of the two curves near the TI concentration of edible grade soy flour predicts that protein level in the diet can be expected to have essentially no effect on the incidence of AA when TI activity is in this range. But, for proteins containing greater concentrations of TI, increasing the level of protein in the diet will increase the incidence of pancreatic pathology, while for proteins with quite low levels of TI, increasing the protein in the diet above 10% will have a protective effect.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Safety of trypsin inhibitors in the diet: effects on the rat pancreas of long-term feeding of soy flour and soy protein isolate. 379 82